Notice for sotorasib (Amgen Australia Pty Ltd)
Active ingredients
sotorasib
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Film-coated tablet
Indication
For the treatment of KRASG12C-mutated non-small cell lung cancer (NSCLC)
Therapeutic area
Oncology